Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis
Daniela Vicente Bavaresco, Maria Laura Rodrigues Uggioni, Sarah Dagostin Ferraz, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 188, pp. 172838-172838
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
Gian Marco Leone, Katia Mangano, Maria Cristina Petralia, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1630-1630
Open Access | Times Cited: 87
C-Reactive Protein as a Biomarker for Major Depressive Disorder?
Laura Orsolini, Simone Pompili, Silvia Tempia Valenta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1616-1616
Open Access | Times Cited: 84
Biological factors influencing depression in later life: role of aging processes and treatment implications
Sarah M. Szymkowicz, Andrew Gerlach, Damek Homiack, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 66
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
Thomas Frisell, Hannah Bower, Matilda Morin, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 5, pp. 601-610
Open Access | Times Cited: 53
The molecular pathophysiology of depression and the new therapeutics
Haihua Tian, Zhenyu Hu, Jia Xu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 70
Anti-TNF-α Compounds as a Treatment for Depression
Sarit Uzzan, Abed N. Azab
Molecules (2021) Vol. 26, Iss. 8, pp. 2368-2368
Open Access | Times Cited: 68
The immunology of stress and the impact of inflammation on the brain and behaviour
Meghna Ravi, Andrew H. Miller, Vasiliki Michopoulos
BJPsych Advances (2021) Vol. 27, Iss. 3, pp. 158-165
Open Access | Times Cited: 60
Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses
Maria S. Simon, Gara Arteaga-Henríquez, Ahmed Fouad Algendy, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1-25
Open Access | Times Cited: 32
Serum claudin-5 levels among patients with unipolar and bipolar depression in relation to the pro-inflammatory cytokine tumor necrosis factor-alpha levels
Eldar Hochman, Michal Taler, Reut Flug, et al.
Brain Behavior and Immunity (2023) Vol. 109, pp. 162-167
Closed Access | Times Cited: 24
The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bedside
Shweta Sharma, Shivani Chawla, Praveen Kumar, et al.
Brain Research (2024) Vol. 1843, pp. 149123-149123
Closed Access | Times Cited: 14
The interface of depression and diabetes: treatment considerations
Giuseppe Fanelli, Emanuel Raschi, Gaye Hafez, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 7
Depression and Autoimmune Hypothyroidism—Their Relationship and the Effects of Treating Psychiatric and Thyroid Disorders on Changes in Clinical and Biochemical Parameters Including BDNF and Other Cytokines—A Systematic Review
Zofia Kotkowska, Dominik Strzelecki
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 391-391
Open Access | Times Cited: 20
The role of polyunsaturated fatty acids in the neurobiology of major depressive disorder and suicide risk
M. Elizabeth Sublette, Federico M. Daray, Licínia Ganança, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 2, pp. 269-286
Closed Access | Times Cited: 11
Activation of the interleukin-23/Th17 axis in major depression: a systematic review and meta-analysis
Calum D. Moulton, Mantas Malys, Christopher W. P. Hopkins, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 4
Research progress on rheumatoid arthritis-associated depression
Nian Liu, Weitian Yan, Rong Su, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 16
Open Access | Times Cited: 10
Innovative approaches in the treatment-resistant depression: exploring different therapeutic pathways
Anna Łysik, Katarzyna Logoń, Aleksandra Szczygieł, et al.
GeroScience (2025)
Open Access
Major Depressive Disorder in Long COVID and Exposure to Pro‐Inflammatory Cytokines During Infection by SARS‐CoV‐2
Hernan Felipe Guillén-Burgos, Juan F Gálvez-Flórez, Sergio Moreno, et al.
Psychiatric Research and Clinical Practice (2025), pp. n/a-n/a
Open Access
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review
Shijin Wu, Yuyang Zhou
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Is There such a Thing as Post-Viral Depression?: Implications for Precision Medicine
Eun‐Sook Park, Chan Young Shin, Se Jin Jeon, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 6, pp. 659-684
Closed Access | Times Cited: 3
Advances in the gut microbiome and mood disorders
Sabrina Mörkl, Mary I. Butler, Sonja Lackner
Current Opinion in Psychiatry (2022) Vol. 36, Iss. 1, pp. 1-7
Closed Access | Times Cited: 13
Efficacy and safety of drugs for psoriasis patients with mental disorders: A systematic review
Meng Wang, Yanhong Sun, Yonghu Sun
Journal of Affective Disorders (2024) Vol. 365, pp. 112-125
Closed Access | Times Cited: 2
New agents and perspectives in the pharmacological treatment of major depressive disorder
Marsal Sanches, João Quevedo, Jair C. Soares
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110157-110157
Open Access | Times Cited: 18
C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders
Laura Orsolini, Simone Pompili, Umberto Volpe
Advances in experimental medicine and biology (2023), pp. 135-160
Closed Access | Times Cited: 6
Dance therapy as an intervention for stress and depression: a systematic review and meta-analysis
Neha Christopher, Ella Dumaresq, Jeanette Tamplin
Body Movement and Dance in Psychotherapy (2024), pp. 1-18
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top